BusinessMyriad Genetics Expands Strategic Research Collaboration With AbbVieBy Nasdaq OMXFeb 23, 2016, 12:05 PM UTC
BusinessINC Research Expands Partnership With Society for Clinical Research Sites to Enhance Site Sustainability on a Global BasisBy Nasdaq OMXFeb 22, 2016, 2:02 PM UTC
BusinessCuris to Release Fourth Quarter and Year End 2015 Financial Results and Hold Conference Call on February 29, 2016By Nasdaq OMXFeb 22, 2016, 12:00 PM UTC
BusinessChromaDex Announces Commencement of an Obesity-Related Clinical Study of NIAGEN® in Collaboration With the University of Copenhagen and Aarhus UniversityBy Nasdaq OMXFeb 22, 2016, 11:30 AM UTC
BusinessPRA Holdings, Inc. Announces Cash Tender Offer for up to $75 Million Aggregate Principal Amount of its 9.500% Senior Notes due 2023By Nasdaq OMXFeb 18, 2016, 10:12 PM UTC
BusinessCatalyst Pharmaceuticals Announces Participation at SunTrust Robinson Humphrey’s 2016 Orphan Drug DayBy Nasdaq OMXFeb 18, 2016, 4:38 PM UTC
BusinessPortola Pharmaceuticals Announces Biologics License Application for Andexanet Alfa Accepted for Review by FDABy Nasdaq OMXFeb 17, 2016, 10:42 PM UTC
BusinessRevance Therapeutics to Release Fourth Quarter and Full Year 2015 Financial Results Wednesday, March 2, 2016By Nasdaq OMXFeb 17, 2016, 9:05 PM UTC